Biblio
“Small RNA Sequencing in the Tg4-42 Mouse Model Suggests the Involvement of snoRNAs in the Etiology of Alzheimer's Disease.”, J Alzheimers Dis, vol. 87, no. 4, pp. 1671-1681, 2022.
, “The Spectrum of Alzheimer-Type Pathology in Cognitively Normal Individuals.”, J Alzheimers Dis, vol. 91, no. 2, pp. 683-695, 2022.
, “Subjective Cognitive Decline: Is a Resilient Personality Protective Against Progression to Objective Cognitive Impairment? Findings from Two Community-Based Cohort Studies.”, J Alzheimers Dis, vol. 89, no. 1, pp. 87-105, 2022.
, “Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer's Disease.”, J Alzheimers Dis, vol. 90, no. 1, pp. 233-249, 2022.
, “Systemic Injection of Aged Blood Plasma in Adult C57BL/6 Mice Induces Neurophysiological Impairments in the Hippocampal CA1.”, J Alzheimers Dis, vol. 89, no. 1, pp. 283-297, 2022.
, “A Tale of Two Diseases: Exploring Mechanisms Linking Diabetes Mellitus with Alzheimer's Disease.”, J Alzheimers Dis, vol. 85, no. 2, pp. 485-501, 2022.
, “Transcriptome and Translatome Regulation of Pathogenesis in Alzheimer's Disease Model Mice.”, J Alzheimers Dis, vol. 86, no. 1, pp. 365-386, 2022.
, “Traumatic Brain Injury and Risk of Alzheimer's Disease and Related Dementias in the Population.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1049-1059, 2022.
, “Undiagnosed Dementia Is Associated with Poor Physical Function in Older Adults.”, J Alzheimers Dis, vol. 89, no. 2, pp. 473-482, 2022.
, “Visually Identified Tau 18F-MK6240 PET Patterns in Symptomatic Alzheimer's Disease.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1627-1637, 2022.
, “Weight Loss and Alzheimer's Disease in Down Syndrome.”, J Alzheimers Dis, vol. 91, no. 3, pp. 1215-1227, 2022.
, “Yoga Prevents Gray Matter Atrophy in Women at Risk for Alzheimer's Disease: A Randomized Controlled Trial.”, J Alzheimers Dis, vol. 87, no. 2, pp. 569-581, 2022.
, “α-Lipoic Acid Has the Potential to Normalize Copper Metabolism, Which Is Dysregulated in Alzheimer's Disease.”, J Alzheimers Dis, vol. 85, no. 2, pp. 715-728, 2022.
, “A 19-Year-Old Adolescent with Probable Alzheimer's Disease.”, J Alzheimers Dis, vol. 91, no. 3, pp. 915-922, 2023.
, “Accumulation of pTau231 at the Postsynaptic Density in Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 1, pp. 241-260, 2023.
, “Activation of TNF Receptor 2 Improves Synaptic Plasticity and Enhances Amyloid-β Clearance in an Alzheimer's Disease Mouse Model with Humanized TNF Receptor 2.”, J Alzheimers Dis, vol. 94, no. 3, pp. 977-991, 2023.
, “Advanced Alzheimer's Disease Patients Show Safe, Significant, and Persistent Benefit in 6-Month Bryostatin Trial.”, J Alzheimers Dis, vol. 96, no. 2, pp. 759-766, 2023.
, “Age-Related Association Between APOE ɛ4 and Cognitive Progression in de novo Parkinson's Disease.”, J Alzheimers Dis, vol. 91, no. 3, pp. 1121-1132, 2023.
, “An Alternative View of Familial Alzheimer's Disease Genetics.”, J Alzheimers Dis, vol. 96, no. 1, pp. 13-39, 2023.
, “Alzheimer's Disease: A Systems View Provides a Unifying Explanation of Its Development.”, J Alzheimers Dis, vol. 91, no. 1, pp. 43-70, 2023.
, “Alzheimer's Disease and Neurosyphilis: Meaningful Commonalities and Differences of Clinical Phenotype and Pathophysiological Biomarkers.”, J Alzheimers Dis, vol. 94, no. 2, pp. 611-625, 2023.
, “The Alzheimer's Disease Mitochondrial Cascade Hypothesis: A Current Overview.”, J Alzheimers Dis, vol. 92, no. 3, pp. 751-768, 2023.
, “Alzheimer's Disease Pathology Outside of the Cerebrum Is Related to a Higher Odds of Dementia.”, J Alzheimers Dis, vol. 96, no. 2, pp. 563-578, 2023.
, “The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes.”, J Alzheimers Dis, vol. 94, no. 2, pp. 497-507, 2023.
, “Apathy as a Predictor of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Texas Alzheimer's Research and Care Consortium (TARCC) Cohort-Based Analysis.”, J Alzheimers Dis, vol. 92, no. 1, pp. 129-139, 2023.
,